Company NewsThe current position： > en > News Center > Company News >
Leadman Held Investor Meeting
作者：Leadman日期：2014-11-04
October 31th,2014,PM 02:30,Leadman held Investor Meeting to communicate with investors their concerning issues about company management,developing strategies,current assets, fund-raising plans,equity motivation,sustainable development.
Leadman Chairman Mr.Shen Guangqian,Vice Chairman&CEO Mr.Wang Yixing,Vice President Mr.Chenyudong,Board Secretary Mr.Niu Juhui,Assitant to Vice President for operations Mr.Ma Zhiyuan,and more than 60 guests from various circles attended the meeting.
Afer a summarizing report of 2014 investment by Mr.Niu,they demonstrated and explained about issues including the launch of self-developed instrument—CI1000, success in getting certificate for IDS instrument,cooperation with Enigma,and every question from guests.
Investors show highly recognition on asset-restructuring moves of Leadman,and expect Leadman not only to consolidate the leading position in biochemical diagnostic field,and also to seize more market share in immunodiagnosis and molecular diagnostic fields.
Leadman Chairman Mr.Shen Guangqian,Vice Chairman&CEO Mr.Wang Yixing,Vice President Mr.Chenyudong,Board Secretary Mr.Niu Juhui,Assitant to Vice President for operations Mr.Ma Zhiyuan,and more than 60 guests from various circles attended the meeting.
Afer a summarizing report of 2014 investment by Mr.Niu,they demonstrated and explained about issues including the launch of self-developed instrument—CI1000, success in getting certificate for IDS instrument,cooperation with Enigma,and every question from guests.
Investors show highly recognition on asset-restructuring moves of Leadman,and expect Leadman not only to consolidate the leading position in biochemical diagnostic field,and also to seize more market share in immunodiagnosis and molecular diagnostic fields.
分享到：
